日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Green vessel signal on multicolor imaging as an early sign of ischemic vasculitis in IRVAN Syndrome: A case report

多色成像中绿色血管信号作为IRVAN综合征缺血性血管炎的早期征象:病例报告

Markowitz, Daniel M; Nimworaphan, Jirat; Regillo, Carl D; Dunn, James P; Sergott, Robert C

TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration

TALON IIIb期研究:采用“治疗-延长”策略,比较brolucizumab与aflibercept治疗新生血管性年龄相关性黄斑变性的64周结果

Regillo, Carl; Kaiser, Peter K; Kertes, Peter J; Gillies, Mark; Maio-Twofoot, Tina; Lawrence, David; Holz, Frank G

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

持续使用端口输注系统给予雷珠单抗与每月一次给予雷珠单抗治疗糖尿病性黄斑水肿:宝塔随机临床试验

Khanani, Arshad M; Campochiaro, Peter A; Graff, Jordan M; Marcus, Dennis M; Miller, Daniel; Mittra, Robert A; Regillo, Carl; Sheth, Veeral S; Bobbala, Ashwini; Gune, Shamika; Lin, Stephanie; Quezada-Ruiz, Carlos; Malhotra, Varun

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform

植入和补充针的结构更新(端口输送平台)

Pieramici, Dante J; Campochiaro, Peter A; Chang, Margaret; Pearce, Ian; Regillo, Carl D; Gune, Shamika; Holekamp, Nancy; Quezada-Ruiz, Carlos; Ranade, Shrirang V; Singh, Natasha; Wise, Geoffrey; Horvath, Joshua

Anti-Vascular Endothelial Growth Factor Therapy for Stages 3 and 4 Proliferative Sickle Cell Retinopathy Results in Improved Anatomic and Visual Outcomes

抗血管内皮生长因子疗法治疗3期和4期增生性镰状细胞视网膜病变可改善解剖结构和视觉结果

Lim, Jennifer I; Okonkwo, Ogugua N; Ong, Sally S; Regillo, Carl D; Scott, Adrienne W; Wykoff, Charles C; Cao, Jessica; Chen, Alicia; Miao, Bernadette A; Momenaei, Bita; Liu, Jianyou

Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan

玻璃体内注射培塞他考普兰后眼内压的短期变化

Momenaei, Bita; Wakabayashi, Taku; Adams, Olufemi E; Wang, Kristine; Regillo, Carl D; Spirn, Marc; Ho, Allen C; Hsu, Jason; Kaiser, Richard; Yonekawa, Yoshihiro; Orlin, Anton; Garg, Sunir J

Epiretinal Membrane Progression Following Cataract Surgery

白内障手术后视网膜前膜进展

Momenaei, Bita; Shahlaee, Abtin; Nguyen, Michael K; Yu, Julia; Martin, Jonathan; Israilevich, Rachel; Fineman, Mitchell S; Regillo, Carl D; Gupta, Omesh P; Kaiser, Richard S; Ho, Allen C; Hsu, Jason

FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings - FORCE study

FYB-201 雷珠单抗生物类似药(Ongavia/Ranivisio/Cimerli)在临床环境中的疗效和安全性 - FORCE 研究

Sharma, Ashish; Nicholson, Luke; Vazquez-Alfageme, Clara; Sivagnanavel, Vasuki; Fausto, Riccardo; Soare, Maria Cristina; Salamanca, Marta Bautista; Fabozzi, Lorenzo; Tsika, Chrysanthi; Corbalan, Olga Cejudo; Verdejo, Alejandro Gomez; Wakabayashi, Taku; Woo, Se Joon; Kolomeyer, Anton M; Mansour, Hana; Momenaei, Bita; Regillo, Carl D

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

在美国开展的一项前瞻性、为期两年、多中心1期临床试验(OPTIC),旨在评估ixoberogene soroparvovec治疗新生血管性年龄相关性黄斑变性的安全性和有效性。

Khanani, Arshad M; Boyer, David S; Wykoff, Charles C; Regillo, Carl D; Busbee, Brandon G; Pieramici, Dante; Danzig, Carl J; Joondeph, Brian C; Major, James C Jr; Turpcu, Adam; Kiss, Szilárd

Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal Diseases

探索糖尿病视网膜病变的相关遗传病因,以此作为视网膜疾病炎症的模型

Cappellani, Francesco; Regillo, Carl D; Haller, Julia A; Gagliano, Caterina; Pulido, Jose S